Tumoral and tissue-specific expression of the major human beta-tubulin isotypes
Luis J Leandro-García1, Susanna Leskelä, Iñigo Landa
1Hereditary Endocrine Cancer Group, Human Cancer Genetics Programme, Spanish National Cancer Research Center (CNIO), Melchor Fernández Almagro n 3, Madrid, Spain.
Abstract:
The beta-tubulins are microtubule components encoded by a multigene family, which produces slightly different proteins with complex expression patterns. Several widely used anticancer drugs base their activity on beta-tubulin binding, microtubule dynamics alteration, and cell division blockage. The expression of these drug targets in tumoral and normal cells could be of crucial importance for therapy outcome, unfortunately, the complex beta-tubulin expression patterns have been poorly characterized in human. In this study, we developed a quantitative RT-PCR technique that accurately determines the mRNA expression of the eight human beta-tubulin isotypes, encoding class I, IIa, IIb, III, IVa, IVb, V, and VI and applied it to 21 nontumoral tissues and 79 tumor samples belonging to seven cancer types. In the nontumoral tissues, we found that, overall, TUBB (I), TUBB2C (IVb), and TUBB6 (V) were ubiquitous, TUBB1(VI) was hematopoietic cell-specific, and TUBB2A (IIa), TUBB2B (IIb), TUBB3 (III), and TUBB4 (IVa) had high expression in brain; however, the contribution of the different isotypes to the total beta-tubulin content varied for each tissue and had a complex pattern. In tumoral tissues, most isotypes exhibited an altered expression in specific tumor types or related to tumoral characteristics. In general, TUBB3 showed a great increase in expression while TUBB6 expression was largely decreased in most tumors. Thus, normal tissues showed a complex beta-tubulin isotype distribution, which could contribute to the toxicity profile of the microtubule-binding drugs. In addition, the specific isotypes significantly altered in tumors might represent markers for drug response.
Insights
Beta-tubulin isotype expression varies in normal human tissues and is altered in tumors. Understanding these patterns is key for predicting anticancer drug response and toxicity.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Beta-tubulins are crucial microtubule components encoded by a multigene family.
- Anticancer drugs targeting beta-tubulins disrupt cell division, but their efficacy is limited by complex expression patterns in normal and tumor cells.
- Human beta-tubulin isotype expression patterns remain poorly understood, hindering therapeutic optimization.
Purpose of the Study:
- To develop a quantitative RT-PCR method for analyzing human beta-tubulin isotype mRNA expression.
- To characterize the expression profiles of eight human beta-tubulin isotypes in various normal and tumor tissues.
- To investigate the potential of beta-tubulin isotypes as biomarkers for anticancer drug response.
Main Methods:
- Quantitative RT-PCR technique developed to measure mRNA expression of eight human beta-tubulin isotypes (Class I-VI).
- Analysis of beta-tubulin isotype expression in 21 non-tumoral human tissues and 79 tumor samples across seven cancer types.
- Comparison of expression patterns between normal and tumoral tissues, and correlation with tumoral characteristics.
Main Results:
- Normal tissues exhibit a complex, tissue-specific distribution of beta-tubulin isotypes, with some being ubiquitous and others cell-specific (e.g., TUBB1 in hematopoietic cells).
- High expression of TUBB2A, TUBB2B, TUBB3, and TUBB4 isotypes was observed in brain tissue.
- Tumoral tissues generally show altered beta-tubulin isotype expression, with TUBB3 often increased and TUBB6 decreased across most tumor types.
- Specific isotype alterations in tumors may correlate with tumoral characteristics.
Conclusions:
- Normal human tissues display intricate beta-tubulin isotype expression patterns that could influence the toxicity of microtubule-binding drugs.
- Altered expression of specific beta-tubulin isotypes in tumors suggests their potential as predictive markers for drug response.
- Further research into beta-tubulin isotype expression is warranted for personalized cancer therapy development.
Related Concept Videos
General Transcription Factors
Microtubule Instability
Transcription Factors
Microtubules
Microtubules have two structurally similar globular protein subunits: α and β tubulins. In the cytosol, the α and β tubulins form a heterodimer. These αβ-heterodimers...
Microtubule Formation
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...


